Human platelets tau: A potential peripheral marker for Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 25, Issue 1, 2011, Pages 103-109

  Neumann, Karen ^a   Farías, Gonzalo ^a,b   Slachevsky, Andrea ^b,c,d   Perez, Patricio ^a   MacCioni, Ricardo B ^a,b,c  

^a UNIVERSITY OF CHILE   (Chile)

^b International Center for Biomedicine ICC   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d HOSPITAL DEL SALVADOR   (Chile)

Author keywords

Alzheimer's disease; cognitive impairment; human platelets; molecular biomarkers; protein self aggregation; tau proteins

Indexed keywords

OLIGOMER; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE; THROMBOCYTE;

EID: 79959650192     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-101641     Document Type: Article

References (27)

1. Maccioni RB, Munoz JP, Barbeito L (2001) The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32, 367-381. (Pubitemid 32918139)
2. Cummings JL, Doody R, Clark C (2007) Disease-modifying therapies for Alzheimer disease: Challenges to early intervention. Neurology 69, 1622-1634. (Pubitemid 350287147)
3. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger- Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746. (Pubitemid 47058377)
4. Lavados M, Farias G, Rothhammer F, Guillon M, Mujica MC, Maccioni C, Maccioni RB (2005) ApoE alleles and tau markers in patients with different levels of cognitive impairment. Arch Med Res 36, 474-479. (Pubitemid 41140051)
5. Maccioni RB, Lavados M, Guillon M, Mujica C, Bosch R, Farias G, Fuentes P (2006) Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects. Neurobiol Aging 27, 237-244. (Pubitemid 43038547)
6. Maccioni RB, Lavados M, Maccioni CB, Mendoza-Naranjo A (2004) Biological markers of Alzheimer's disease and mild cognitive impairment. Curr Alzheimer Res 1, 307-314.
7. Sonnen JA,Keene CD, Montine KS, Li G, Peskind ER, Zhang J, Montine TJ (2007) Biomarkers for Alzheimer's disease. Expert Rev Neurother 7, 1021-1028. (Pubitemid 47281316)
8. Borroni B, Colciaghi F, Pastorino L, Pettenati C, Cottini E, Rozzini L, Monastero R, Lenzi GL, Cattabeni F, Di Luca M, Padovani A (2001) Amyloid precursor protein in platelets of patients with Alzheimer disease: Effect of acetylcholinesterase inhibitor treatment. Arch Neurol 58, 442-446. (Pubitemid 32217461)
9. Padovani A, Pastorino L, Borroni B, Colciaghi F, Rozzini L, Monastero R, Perez J, Pettenati C, Mussi M, Parrinello G, Cottini E, Lenzi GL, Trabucchi M, Cattabeni F, Di Luca M (2001) Amyloid precursor protein in platelets: A peripheral marker for the diagnosis of sporadic AD. Neurology 57, 2243-2248. (Pubitemid 34016458)
10. Colciaghi F, Marcello E, Borroni B, Zimmermann M, Caltagirone C, Cattabeni F, Padovani A, Di Luca M (2004) Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology 62, 498-501. (Pubitemid 38200872)
11. Borroni B, Colciaghi F, Caltagirone C, Rozzini L, Broglio L, Cattabeni F, Di Luca M, Padovani A (2003) Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: A 2-year follow-up study. Arch Neurol 60, 1740-1744. (Pubitemid 37521629)
12. Padovani A, Borroni B, Colciaghi F, Pettenati C, Cottini E, Agosti C, Lenzi GL, Caltagirone C, Trabucchi M, Cattabeni F, Di Luca M (2002) Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol 59, 71-75. (Pubitemid 34052558)
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
14. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
15. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139, 1136-1139. (Pubitemid 12051593)
16. Rao GH (1988) Measurement of ionized calcium in normal human blood platelets. Anal Biochem 169, 400-404. (Pubitemid 18081410)
17. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
18. KlunkWE(1998) Biological markers of Alzheimer's disease. Neurobiol Aging 19, 145-147. (Pubitemid 28167755)
19. Maccioni RB, Cambiazo V (1995) Role of microtubuleassociated proteins in the control of microtubule assembly. Physiol Rev 75, 835-864.
20. Drubin D, Kobayashi S, Kellogg D, Kirschner M (1988) Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells. J Cell Biol 106, 1583-1591.
21. Nunez J, Fischer I (1997) Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration. J Mol Neurosci 8, 207-222. (Pubitemid 127500856)
22. Couchie D, Mavilia C, Georgieff IS, Liem RK, Shelanski ML, Nunez J (1992) Primary structure of high molecular weight tau present in the peripheral nervous system. Proc Natl Acad Sci U S A 89, 4378-4381.
23. Gache Y, Guilleminot J, Bridoux AM, Nunez J (1993) Heterogeneity of the high molecular weight tau proteins in N115 neuroblastoma cells. J Neurochem 61, 873-880. (Pubitemid 23241223)
24. GacheY, Guilleminot J, Ricolfi F, Theiss G, Nunez J (1992)A tau-related protein of 130 kDa is present in Alzheimer brain. J Neurochem 58, 2005-2010.
25. Mavilia C, Couchie D, Nunez J (1994) Diversity of highmolecular- weight tau proteins in different regions of the nervous system. J Neurochem 63, 2300-2306. (Pubitemid 24370008)
26. Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M, Wszolek Z, Ashe K, Knight J, Dickson D, Andorfer C, Rosenberry TL, Lewis J, Hutton M, Janus C (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci 27, 3650-3662. (Pubitemid 46557687)
27. Maccioni RB, Farias G, Morales I, Navarrete L (2010) The revitalized tau hypothesis on Alzheimer's disease. Arch Med Res 41, 226-231.